Company profile
Wave Life Sciences, Inc. insider acquisitions
Company CIK 0001631574 · Reported insider acquisitions and filing context.
WVE · Nasdaq
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition
40 dated transactions · 8 of 14 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 5, 2026 | Wave Life Sciences, Inc.Stock Option (Right to Buy) | RA Capital Healthcare Fund LP · RA CAPITAL MANAGEMENT, L.P. · Kolchinsky Peter · Shah Rajeev M. | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Common Stock | RA Capital Healthcare Fund LP · RA CAPITAL MANAGEMENT, L.P. · Kolchinsky Peter · Shah Rajeev M. | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Stock Option (right to buy) | Verdine Gregory L. | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Common Stock | Verdine Gregory L. | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Stock Option (right to buy) | Tan Aik Na | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Common Stock | Tan Aik Na | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Stock Option (right to buy) | TAKANASHI KEN | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Common Stock | TAKANASHI KEN | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Stock Option (right to buy) | CORRIGAN MARK | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Common Stock | CORRIGAN MARK | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Stock Option (right to buy) | Rawcliffe Adrian | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Common Stock | Rawcliffe Adrian | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Stock Option (right to buy) | HENRY CHRISTIAN O | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Common Stock | HENRY CHRISTIAN O | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Stock Option (right to buy) | Wagner Heidi L | Stock award |
| Oct 5, 2026 | Wave Life Sciences, Inc.Common Stock | Wagner Heidi L | Stock award |
| Dec 11, 2025 | Wave Life Sciences, Inc.Ordinary Shares | GSK plc | Purchase |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Rawcliffe Adrian | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | HENRY CHRISTIAN O | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | HENRY CHRISTIAN O | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | HENRY CHRISTIAN O | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Tan Aik Na | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Tan Aik Na | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Tan Aik Na | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Tan Aik Na | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Francis Chris | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Francis Chris | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Francis Chris | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Francis Chris | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Francis Chris | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Francis Chris | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Francis Chris | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Francis Chris | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Francis Chris | Exercise / conversion |
| Dec 9, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Moran Kyle | Exercise / conversion |
| Dec 9, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Moran Kyle | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Moran Kyle | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Moran Kyle | Exercise / conversion |
| Dec 8, 2025 | Wave Life Sciences, Inc.Ordinary Shares | Moran Kyle | Exercise / conversion |
| Nov 13, 2025 | Wave Life Sciences, Inc.Ordinary Shares | RA Capital Healthcare Fund LP · RA CAPITAL MANAGEMENT, L.P. · Kolchinsky Peter · Shah Rajeev M. | Purchase |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
WVE · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | RA Capital Healthcare Fund LPDirector · 10% owner RA CAPITAL MANAGEMENT, L.P.Director · 10% owner Kolchinsky PeterDirector · 10% owner Shah Rajeev M.Director · 10% owner Joint filing · amounts unallocated | Stock awardStock Option (Right to Buy)Derivative security · Code A | 64,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | RA Capital Healthcare Fund LPDirector · 10% owner RA CAPITAL MANAGEMENT, L.P.Director · 10% owner Kolchinsky PeterDirector · 10% owner Shah Rajeev M.Director · 10% owner Joint filing · amounts unallocated | Stock awardCommon StockNon-derivative security · Code A | 10,700 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Verdine Gregory L.Director | Stock awardStock Option (right to buy)Derivative security · Code A | 64,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Verdine Gregory L.Director | Stock awardCommon StockNon-derivative security · Code A | 10,700 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Tan Aik NaDirector | Stock awardStock Option (right to buy)Derivative security · Code A | 64,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Tan Aik NaDirector | Stock awardCommon StockNon-derivative security · Code A | 10,700 | 0Value: 0Currency not specified | View ↗ |
| Trade: | TAKANASHI KENDirector | Stock awardStock Option (right to buy)Derivative security · Code A | 64,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | TAKANASHI KENDirector | Stock awardCommon StockNon-derivative security · Code A | 10,700 | 0Value: 0Currency not specified | View ↗ |
| Trade: | CORRIGAN MARKDirector | Stock awardStock Option (right to buy)Derivative security · Code A | 64,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | CORRIGAN MARKDirector | Stock awardCommon StockNon-derivative security · Code A | 10,700 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Rawcliffe AdrianDirector | Stock awardStock Option (right to buy)Derivative security · Code A | 64,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Rawcliffe AdrianDirector | Stock awardCommon StockNon-derivative security · Code A | 10,700 | 0Value: 0Currency not specified | View ↗ |
| Trade: | HENRY CHRISTIAN ODirector | Stock awardStock Option (right to buy)Derivative security · Code A | 64,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | HENRY CHRISTIAN ODirector | Stock awardCommon StockNon-derivative security · Code A | 10,700 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Wagner Heidi LDirector | Stock awardStock Option (right to buy)Derivative security · Code A | 64,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Wagner Heidi LDirector | Stock awardCommon StockNon-derivative security · Code A | 10,700 | 0Value: 0Currency not specified | View ↗ |
| Trade: | GSK plc10% owner | PurchaseOrdinary SharesNon-derivative security · Code P | 1,470,000 | 19Value: 27,930,000Currency not specified | View ↗ |
| Trade: | Rawcliffe AdrianDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 42,000 | 5.97Value: 250,740Currency not specified | View ↗ |
| Trade: | HENRY CHRISTIAN ODirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 30,000 | 4.585Value: 137,550Currency not specified | View ↗ |
| Trade: | HENRY CHRISTIAN ODirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 15,000 | 3.5Value: 52,500Currency not specified | View ↗ |
| Trade: | HENRY CHRISTIAN ODirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 42,000 | 5.97Value: 250,740Currency not specified | View ↗ |
| Trade: | Tan Aik NaDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 21,000 | 5.97Value: 125,370Currency not specified | View ↗ |
| Trade: | Tan Aik NaDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 21,000 | 3.5Value: 73,500Currency not specified | View ↗ |
| Trade: | Tan Aik NaDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 45,000 | 4.585Value: 206,325Currency not specified | View ↗ |
| Trade: | Tan Aik NaDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 32,230 | 5.37Value: 173,075.1Currency not specified | View ↗ |
| Trade: | Francis ChrisSee Remarks | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 22,500 | 2.83Value: 63,675Currency not specified | View ↗ |
| Trade: | Francis ChrisSee Remarks | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 50,000 | 10.48Value: 524,000Currency not specified | View ↗ |
| Trade: | Francis ChrisSee Remarks | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 122,349 | 4.75Value: 581,157.75Currency not specified | View ↗ |
| Trade: | Francis ChrisSee Remarks | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 17,900 | 3.87Value: 69,273Currency not specified | View ↗ |
| Trade: | Francis ChrisSee Remarks | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 37,500 | 3.14Value: 117,750Currency not specified | View ↗ |
| Trade: | Francis ChrisSee Remarks | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 9,375 | 3.14Value: 29,437.5Currency not specified | View ↗ |
| Trade: | Francis ChrisSee Remarks | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 45,882 | 4.75Value: 217,939.5Currency not specified | View ↗ |
| Trade: | Francis ChrisSee Remarks | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 107,400 | 3.87Value: 415,638Currency not specified | View ↗ |
| Trade: | Francis ChrisSee Remarks | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 28,125 | 3.14Value: 88,312.5Currency not specified | View ↗ |
| Trade: | Moran KyleChief Financial Officer | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 50,000 | 10.48Value: 524,000Currency not specified | View ↗ |
| Trade: | Moran KyleChief Financial Officer | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 36,000 | 8.17Value: 294,120Currency not specified | View ↗ |
| Trade: | Moran KyleChief Financial Officer | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 50,000 | 4.75Value: 237,500Currency not specified | View ↗ |
| Trade: | Moran KyleChief Financial Officer | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 100,000 | 3.14Value: 314,000Currency not specified | View ↗ |
| Trade: | Moran KyleChief Financial Officer | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 60,000 | 2.83Value: 169,800Currency not specified | View ↗ |
| Trade: | RA Capital Healthcare Fund LPDirector · 10% owner RA CAPITAL MANAGEMENT, L.P.Director · 10% owner Kolchinsky PeterDirector · 10% owner Shah Rajeev M.Director · 10% owner Joint filing · amounts unallocated | PurchaseOrdinary SharesNon-derivative security · Code P | 1,000 | 6.6875 *Value: 6,687.5Currency not specified | View ↗ |
40 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →